Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
BREYANZI CAR T CELL LYMPHOMA THERAPY is a federal award for 249-Network Contract Office 9 (36C249) held by Bristol-Myers Squibb Company. Estimated value $311K ($311K obligated). Current period of performance ends Apr 1, 2024. Last award drew 1 bidder. Place of performance: IRVING TX.
Recompete timing
PublicCurrent PoP ended Apr 1, 2024 (872 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordBristol-Myers Squibb Company — $17.3M obligated across 91 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24924N0363?
36C24924N0363 (Breyanzi CAR t CELL lymphoma therapy) is a 249-Network Contract Office 9 (36C249) award with a potential value of $311K, currently held by Bristol-Myers Squibb Company. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C249-24-N-0363?
36C249-24-N-0363 is the dashed form of PIID 36C24924N0363 (Breyanzi CAR t CELL lymphoma therapy), held by Bristol-Myers Squibb Company. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24924N0363?
249-Network Contract Office 9 (36C249) awarded 36C24924N0363 to Bristol-Myers Squibb Company (potential $311K).
Who is the incumbent on 36C24924N0363?
Bristol-Myers Squibb Company is the incumbent with $17.3M across 91 related awards in SCOUT’s public footprint. The current period of performance ends Apr 1, 2024.
When does Bristol-Myers Squibb Company’s 36C24924N0363 come up for recompete?
SCOUT tracks a period-of-performance end of Apr 1, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.